Ocular Manifestations of Human Immunodeficiency Virus Infection at a Tertiary Referral Center in Taiwan

References

• Twu S-J, Huang Y-F, Lai A-C, Ming N, Su I-J. Update and projection on HIV/AIDS in Taiwan. AIDS Educ Prev. 2004;16(Supplement A):53–63. doi:10.1521/aeap.16.3.5.53.35530.
   PubMed Web of Science ®Google Scholar
• Taiwan Centers for Disease Control and Prevention. [Surveillance of HIV]. In http://www.cdc.gov.tw. [ Accessed 3 February in 2017].
   Google Scholar
• Hodge WG, Seiff SR, Margolis TP. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology. 1998;105:895–900. doi:10.1016/S0161-6420(98)95033-3.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339(4):236–244. doi:10.1056/NEJM199807233390406.
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Rodrigues MDLV, Figueiredo JFDC, De Freitas JAH. Ocular problems in Brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era. Braz J Infect Dis. 2007;11:199–202.
   PubMed Web of Science ®Google Scholar
• Goldberg DE, Smithen LM, Angelilli A, et al. HIV-associated retinopathy in the HAART era. Retina. 2005;25:633–649.
   PubMed Web of Science ®Google Scholar
• Bekele S1, Gelaw Y, Tessema FO. cular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study. BMC Ophthalmol. 2013 May 27;13:20. doi:10.1186/1471-2415-13-20.
   PubMed Web of Science ®Google Scholar
• Lai TY, Wong RL, Luk FO, et al. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Experiment Ophthalmol. 2011;39:99–104. doi:10.1111/j.1442-9071.2010.02400.x.
   PubMed Web of Science ®Google Scholar
• Ausayakhun S, Watananikorn S, Ittipunkul N, et al. Epidemiology of the ocular complications of HIV infection in Chiang Mai. J Med Assoc Thai. 2003;86:399–406.
   PubMedGoogle Scholar
• Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264–271. doi:10.1080/09286580802077716.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park SJ, Yu HG, Kim NJ, Jang H-C, Oh M-D. Ocular manifestations of acquired immunodeficiency syndrome in Korea. J Korean Med Sci. 2012;27:542–546. doi:10.3346/jkms.2012.27.5.542.
   PubMed Web of Science ®Google Scholar
• Pathai S, Deshpande A, Gilbert C, Lawn SD. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. BMC Infect Dis. 2009;9(1):158. doi:10.1186/1471-2334-9-158.
   PubMed Web of Science ®Google Scholar
• Jing LUO, Jing D, Kozak I, et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol. 2013;20(3):170–175. doi:10.3109/09286586.2013.789530.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jia R, Ge S, et al. Ocular complications of human immunodeficiency virus infection in eastern china. Am J Ophthalmol. 2012;153(2):363–369. e1. doi:10.1016/j.ajo.2011.07.018.
   PubMed Web of Science ®Google Scholar
• Wang J, You Q, Yang H, et al. Retinal findings in Chinese patients with HIV infection. Ophthalmic Res. 2008;40:98–100. doi:10.1159/000113888.
   PubMed Web of Science ®Google Scholar
• Uemura A, Yashiro S, Takeda N, et al. Ocular complications in patients with human immunodeficiency virus infection. Nippon Ganka Gakkai Zasshi. 2006;110:698–702.
   PubMedGoogle Scholar
• Nishijima T, Yashiro S, Teruya K, et al. Routine eye screening by an ophthalmologist is clinically useful for HIV-1-infected patients with CD4 count less than 200/μL. PloS One. 2015;10(9):e0136747. doi:10.1371/journal.pone.0136747.
   PubMed Web of Science ®Google Scholar
• Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397–408. doi:10.1016/j.ajo.2007.12.001.
   PubMed Web of Science ®Google Scholar
• Chiou SH, Liu CY, Hsu WM, et al. Ophthalmic findings in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect. 2000;33:45–48.
   PubMedGoogle Scholar
• Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol. 2004;49:131–157. doi:10.1016/j.survophthal.2003.12.008.
   PubMed Web of Science ®Google Scholar
• Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 years prospective study. Br J Ophthalmol. 1999;83:652–655.
   PubMed Web of Science ®Google Scholar
• Doan S, Cochereau I, Guvenisik N, Diraison MC, Mousalatti H, Thanh HX. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol. 1999;128:250–251.
   PubMed Web of Science ®Google Scholar
• Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4 counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575–582. doi:10.1016/S0002-9394(14)71453-9.
   PubMed Web of Science ®Google Scholar
• Tsen CL, Chen SC, Chen YS, et al. Uveitis as an initial manifestation of acquired immunodeficiency syndrome. Int J STD AIDS. 2017; 28(12): 1224–1228.
   PubMed Web of Science ®Google Scholar
• Balba GP, Kumar PN, James AN, et al. Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med. 2006;119(5):448. e21-448. e25. doi:10.1016/j.amjmed.2005.11.016.
   PubMed Web of Science ®Google Scholar
• McLeish WM, Pulido JS, Holland S, et al. The ocular manifestations of syphilis in the human immunodeficiency virus type1-infected host. Ophthalmology. 1990;97:196–203.
   PubMed Web of Science ®Google Scholar
• Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 2000;107:2015–2023. doi:10.1016/S0161-6420(00)00457-7.
   PubMed Web of Science ®Google Scholar
• Balba GP, Kumar PN, James AN, et al. Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med. 2006;119(5):448.e21-5. doi:10.1016/j.amjmed.2005.11.016.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976. doi:10.1016/S0140-6736(04)16412-X.
   PubMed Web of Science ®Google Scholar
• Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264–296. doi:10.1128/CMR.05013-11.
   PubMed Web of Science ®Google Scholar
• Zeller V, Caumes E, Bossi P, Bricaire F. Katlama C.Current clinical aspects of HIV/AIDS. Presse Med. 2002;31:74–79.
   PubMed Web of Science ®Google Scholar
• Fang C-T, Hsu H-M, Twu S-J, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004;190(5):879–885. doi:10.1086/422601.
   PubMed Web of Science ®Google Scholar